Page last updated: 2024-08-21

3-hydroxyflavone and Granulocytic Leukemia, Chronic

3-hydroxyflavone has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antosik, P; Czajkowska, P; Durślewicz, J; Gagat, M; Grzanka, A; Grzanka, D; Hałas-Wiśniewska, M; Klimaszewska-Wiśniewska, A	1

Other Studies

1 other study(ies) available for 3-hydroxyflavone and Granulocytic Leukemia, Chronic

Article	Year
Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells. International journal of oncology, 2019, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2019

Article

Year

Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.

International journal of oncology, 2019, Volume: 55, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2019